These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 11347144)

  • 1. [Endogenous hypertriglyceridemia].
    Kotake H; Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():63-8. PubMed ID: 11347144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Familial hypertriglyceridemia].
    Kuwasako T; Yamashita S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():74-8. PubMed ID: 11347165
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe hypertriglyceridaemia in Type II diabetes: involvement of apoC-III Sst-I polymorphism, LPL mutations and apo E3 deficiency.
    Marçais C; Bernard S; Merlin M; Ulhmann M; Mestre B; Rochet-Mingret L; Revol A; Berthezene F; Moulin P
    Diabetologia; 2000 Nov; 43(11):1346-52. PubMed ID: 11126401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary hypertriglyceridemia].
    Kotake H; Oikawa S
    Nihon Rinsho; 1999 Dec; 57(12):2782-8. PubMed ID: 10638213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro catabolism of human very low density lipoproteins: fate of apoproteins B and C.
    Catapano AL; Capurso A; Kinnunen PK
    Artery; 1981; 9(2):87-95. PubMed ID: 7295047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic epistasis in the VLDL catabolic pathway is associated with deleterious variations on triglyceridemia in obese subjects.
    Brisson D; St-Pierre J; Santuré M; Hudson TJ; Després JP; Vohl MC; Gaudet D
    Int J Obes (Lond); 2007 Aug; 31(8):1325-33. PubMed ID: 17342071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
    Ebara T; Ramakrishnan R; Steiner G; Shachter NS
    J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence for linkage between familial hypertriglyceridemia and apolipoprotein B, apolipoprotein C-III or lipoprotein lipase genes.
    Heliö T; Palotie A; Sane T; Tikkanen MJ; Kontula K
    Hum Genet; 1994 Sep; 94(3):271-8. PubMed ID: 8076943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over expression of human apoCIII gene leads to hypertriglyceridemia in transgenic mice.
    Indian J Exp Biol; 1991 Jan; 29(1):99. PubMed ID: 1864630
    [No Abstract]   [Full Text] [Related]  

  • 11. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The familial chylomicronemia syndrome.
    Santamarina-Fojo S
    Endocrinol Metab Clin North Am; 1998 Sep; 27(3):551-67, viii. PubMed ID: 9785052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on duck serum lipoproteins. VIII. Studies on biological activity and metabolism of HDL-apo C II in vitro].
    Li XZ; Wang KQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Apr; 9(2):89-94. PubMed ID: 2955931
    [No Abstract]   [Full Text] [Related]  

  • 15. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
    J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction between genes and diet as a determinant of the plasma levels of cholesterol].
    López Miranda J; Ordovás JM; Pérez Jiménez F
    Med Clin (Barc); 1998 Oct; 111(14):546-51. PubMed ID: 9859082
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial commentary: Dietary management of familial chylomicronemia syndrome.
    Williams L; Wilson DP
    J Clin Lipidol; 2016; 10(3):462-5. PubMed ID: 27206931
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice.
    Ito Y; Azrolan N; O'Connell A; Walsh A; Breslow JL
    Science; 1990 Aug; 249(4970):790-3. PubMed ID: 2167514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The familial hyperchylomicronemia syndrome. New insights into underlying genetic defects.
    Santamarina-Fojo S; Brewer HB
    JAMA; 1991 Feb; 265(7):904-8. PubMed ID: 1992190
    [No Abstract]   [Full Text] [Related]  

  • 20. [Apolipoprotein C III and hypertriglyceridemia].
    Wang JY
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):37-9. PubMed ID: 21417013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.